Pomi-T®
Product Details
Overview:
Pomi-T® contains a specific blend of pomegranate, green tea, turmeric, and broccoli. This superfecta is formulated to maintain healthy levels of prostate-specific antigen (PSA).
Pomi-T® Benefits:
- Pomegranate: it concentrates on prostate tissue, promotes healthy levels of the
inflammatory response inhibits androgen receptor expression and supports healthy cell migration
- Green tea: it maintains healthy prostate-specific antigen levels and supports the body’s
natural defenses against oxidation
- Turmeric: it helps modulate cell signaling mechanisms and support healthy cell
migration
- Broccoli: it helps regulate enzymes in gut and liver tissue that helps maintain healthy
dietary molecules
Supplement Facts
Serving Size 1 vegetarian capsule
Amount Per Serving: |
---|
Pomi-T Super Proprietary Blend Broccoli (florets, stalks) powder, turmeric (root) powder, pomegranate (whole fruit) powder, green tea (leaf) extract 5:1 480 mg |
Other ingredients: vegetable cellulose (capsule), corn starch. |
Non-GMO |
Dosage and Use
- Take one (1) capsule twice daily, with or without food, or as recommended by a healthcare practitioner.
Warnings
- KEEP OUT OF REACH OF CHILDREN
- DO NOT EXCEED RECOMMENDED DOSE
- Do not purchase if the outer seal is broken or damaged.
- When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
To report a serious adverse event or obtain product information, contact (033) 330-3673
More detailed information about this formula
References:
- Available at: http://eu-acme.org/europeanurology/upload_articles/Roehrborn.pdf . Accessed October 2, 2013.
- J Clin Oncol. 2013;31(Suppl; abs 5008).
- Proteomics. 2012 Nov;12(21):3251-62.
- J Agr Food Chem. 2010 Nov 10.
- Mol Cancer Ther. 2008 Sep;7(9):2662-71.
- Evid Based Complement Alternat Med. 2013;2013:247504.
- Int J Oncol. 2008 Feb;32(2):475-80.
- Transl Oncol. 2012 Oct;5(5):344-55.
- J Nutr. 2006 Jul;136(7):1839-43.
- Cancer Lett. 2009 Mar 8;275(1):86-92.
- Int J Mol Med. 2012 Jul;30(1):69-74.
- J Nutr Biochem. 2012 Nov;23(11):1537-42.
- Aaps J. 2013 Jan;15(1):195-218.
- Int J Oncol. 2009 May;34(5):1319-27.
- Prostate. 2001 Jun 1;47(4):293-303.
- Nutr Cancer. 2004;50(2):206-13.
- Cancer. 2003 Dec 1;98(11):2511-20.
- Cancer Prev Res (Phila). 2010 Apr;3(4):484-94.
- PLoS One. 2008;3(7):e2568.